TELA Bio (TELA) Competitors $2.06 +0.05 (+2.24%) As of 10:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. NNOX, SKIN, ZIMV, BSGM, SNWV, DRTS, NYXH, SMTI, CATX, and BWAYShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Nano-X Imaging (NNOX), Beauty Health (SKIN), ZimVie (ZIMV), Biosig Technologies (BSGM), Sanuwave Health (SNWV), Alpha Tau Medical (DRTS), Nyxoah (NYXH), Sanara MedTech (SMTI), Perspective Therapeutics (CATX), and Brainsway (BWAY). These companies are all part of the "medical equipment" industry. TELA Bio vs. Its Competitors Nano-X Imaging Beauty Health ZimVie Biosig Technologies Sanuwave Health Alpha Tau Medical Nyxoah Sanara MedTech Perspective Therapeutics Brainsway Nano-X Imaging (NASDAQ:NNOX) and TELA Bio (NASDAQ:TELA) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends. Do analysts prefer NNOX or TELA? Nano-X Imaging currently has a consensus target price of $9.50, suggesting a potential upside of 91.34%. TELA Bio has a consensus target price of $7.25, suggesting a potential upside of 252.80%. Given TELA Bio's higher possible upside, analysts clearly believe TELA Bio is more favorable than Nano-X Imaging.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has preferable valuation and earnings, NNOX or TELA? TELA Bio has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNano-X Imaging$11.28M25.43-$53.52M-$0.90-5.52TELA Bio$69.30M1.17-$37.84M-$1.41-1.46 Do institutionals & insiders hold more shares of NNOX or TELA? 21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 94.4% of TELA Bio shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to NNOX or TELA? In the previous week, Nano-X Imaging had 2 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Nano-X Imaging and 1 mentions for TELA Bio. Nano-X Imaging's average media sentiment score of 1.89 beat TELA Bio's score of 1.28 indicating that Nano-X Imaging is being referred to more favorably in the media. Company Overall Sentiment Nano-X Imaging Very Positive TELA Bio Positive Is NNOX or TELA more profitable? TELA Bio has a net margin of -61.00% compared to Nano-X Imaging's net margin of -472.19%. Nano-X Imaging's return on equity of -30.92% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets Nano-X Imaging-472.19% -30.92% -27.73% TELA Bio -61.00%-402.45%-62.73% Which has more risk & volatility, NNOX or TELA? Nano-X Imaging has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. SummaryNano-X Imaging beats TELA Bio on 9 of the 16 factors compared between the two stocks. Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$81.69M$2.92B$5.56B$9.28BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-1.4620.3128.6419.62Price / Sales1.17299.14430.8295.68Price / CashN/A43.1536.0257.93Price / Book2.857.658.155.59Net Income-$37.84M-$55.11M$3.24B$257.73M7 Day Performance-3.97%-0.23%-0.64%-0.23%1 Month Performance27.64%7.20%4.92%7.98%1 Year Performance-56.83%-3.60%25.99%13.16% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio2.8605 of 5 stars$2.06+2.2%$7.25+252.8%-57.2%$81.69M$69.30M-1.46120Positive NewsNNOXNano-X Imaging2.5752 of 5 stars$5.12-3.8%$9.50+85.5%-44.7%$307.38M$11.28M-5.69190News CoveragePositive NewsAnalyst UpgradeSKINBeauty Health0.2848 of 5 stars$2.20-3.5%$1.42-35.6%-22.3%$287.27M$334.30M-5.371,030Positive NewsZIMVZimVie1.9935 of 5 stars$9.43-8.0%$16.33+73.2%-53.8%$285.43M$449.75M-13.281,770BSGMBiosig Technologies1.8966 of 5 stars$11.55+11.0%$10.00-13.4%+955.3%$284.14M$40K0.0050News CoverageGap UpHigh Trading VolumeSNWVSanuwave HealthN/A$33.17+4.8%N/AN/A$270.79M$36.19M-7.2840DRTSAlpha Tau Medical3.1263 of 5 stars$3.29+3.8%$8.00+143.2%+48.6%$268.88MN/A-7.1580Positive NewsNYXHNyxoah2.8607 of 5 stars$7.86+1.2%$14.50+84.5%-14.7%$264.65M$4.89M-3.69110Positive NewsSMTISanara MedTech2.337 of 5 stars$29.17-1.6%$49.50+69.7%-8.2%$263.52M$86.67M-21.7760News CoverageHigh Trading VolumeCATXPerspective Therapeutics2.3716 of 5 stars$3.48-5.4%$12.56+260.8%-68.4%$258.31MN/A0.0070News CoverageBWAYBrainsway2.6536 of 5 stars$13.37+1.0%$14.25+6.6%+76.8%$250.17M$41.02M66.85120Gap Up Related Companies and Tools Related Companies Nano-X Imaging Competitors Beauty Health Competitors ZimVie Competitors Biosig Technologies Competitors Sanuwave Health Competitors Alpha Tau Medical Competitors Nyxoah Competitors Sanara MedTech Competitors Perspective Therapeutics Competitors Brainsway Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredMajor Rollout of Social Security X?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.